Patients
Healthcare Professionals
Santen Corporate (EN)
menu
Who We Are
Who We Are
Menu Top
Who We Are
Message from the CEO
Who We Are
Message from the CEO
Santen’s Corporate Philosophy Framework
Who We Are
Santen’s Corporate Philosophy Framework
History of Santen
Who We Are
History of Santen
Corporate Executives
Who We Are
Corporate Executives
Corporate Governance
Who We Are
Corporate Governance
Digital Transformation
Who We Are
Digital Transformation
Policies and Statements
Who We Are
Policies and Statements
Overview / Map
Who We Are
Overview / Map
Global Operations
Who We Are
Global Operations
What We Do
What We Do
Menu Top
What We Do
Medium-Term Management Plan
What We Do
Medium-Term Management Plan
Efforts to Enhance Patients’ Satisfaction
What We Do
Efforts to Enhance Patients’ Satisfaction
Efforts to Enhance Product Usability
Efforts to Enhance Patients’ Satisfaction
Efforts to Enhance Product Usability
Efforts to Address Untreated Patients
Efforts to Enhance Patients’ Satisfaction
Efforts to Address Untreated Patients
Research & Development
What We Do
Research & Development
The Ophthalmic Development Process
Research & Development
The Ophthalmic Development Process
Clinical Trial Information
Research & Development
Clinical Trial Information
Production and Quality Assurance
What We Do
Production and Quality Assurance
Production
Production and Quality Assurance
Production
Safety and Quality Assurance
Production and Quality Assurance
Safety and Quality Assurance
The Ophthalmic Production Process
Production and Quality Assurance
The Ophthalmic Production Process
Partnering
What We Do
Partnering
Santen's Partnership
Partnering
Santen's Partnership
Our Partners
Partnering
Our Partners
Partnering Contact
Partnering
Partnering Contact
Sustainability
Sustainability
Menu Top
Sustainability
Sustainability at Santen
Sustainability
Sustainability at Santen
Environment
Sustainability
Environment
Social
Sustainability
Social
Governance
Sustainability
Governance
Sustainability Library
Sustainability
Sustainability Library
Investor Relations
Investor Relations
Menu Top
Investor Relations
Company Information
Investor Relations
Company Information
Message from the CEO
Company Information
Message from the CEO
Santen’s Corporate Philosophy Framework
Company Information
Santen’s Corporate Philosophy Framework
Medium-Term Management Plan
Company Information
Medium-Term Management Plan
Corporate Governance
Company Information
Corporate Governance
Corporate Executives
Company Information
Corporate Executives
Forward-Looking Statement
Company Information
Forward-Looking Statement
Sustainability
Investor Relations
Sustainability
Sustainability at Santen
Sustainability
Sustainability at Santen
Environment
Sustainability
Environment
Social
Sustainability
Social
Governance
Sustainability
Governance
Library
Sustainability
Library
Sustainability Report
Sustainability
Sustainability Report
IR Library
Investor Relations
IR Library
Latest IR Documents
IR Library
Latest IR Documents
Consolidated Performance
IR Library
Consolidated Performance
Presentation Materials・Videos
IR Library
Presentation Materials・Videos
Integrated Report (Annual Report)
IR Library
Integrated Report (Annual Report)
Data Book
IR Library
Data Book
Pipeline
IR Library
Pipeline
Accounting Standards and Definition of "Core Basis"
IR Library
Accounting Standards and Definition of "Core Basis"
Stock Information
Investor Relations
Stock Information
Stock Information
Stock Information
Stock Information
Materials for the General Meeting of Shareholders
Stock Information
Materials for the General Meeting of Shareholders
Distribution of Profits to Shareholders and Dividends
Stock Information
Distribution of Profits to Shareholders and Dividends
IR Calendar
Stock Information
IR Calendar
Analyst Coverage
Stock Information
Analyst Coverage
Innovation
Investor Relations
Innovation
Efforts to Enhance Patients' Satisfaction
Innovation
Efforts to Enhance Patients' Satisfaction
Research and Development
Innovation
Research and Development
Production
Innovation
Production
Safety and Quality Assurance
Innovation
Safety and Quality Assurance
Careers
Careers
Menu Top
Careers
Our Stories
Our Stories
Menu Top
Our Stories
News
News
Menu Top
News
Home
News
2023 News
Press Release
IR News
Information
Press Release
11.17.2023
Santen Receives European Commission Approval for Catiolanze® (cationic emulsion of latanoprost 50μg/mL) for Lowering of Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension
09.20.2023
Revision of Full-Year Earnings Forecasts
09.13.2023
Santen Publishes its Annual Integrated Report “Santen Report 2023”
09.04.2023
Notice Regarding Implementation of an Early Retirement Program
07.19.2023
Santen Agrees to Licensing Agreements and Asset Transfer for its Pharmaceutical Products in North America
Press Release
IR News
12.01.2023
Santen Announces Status of Share Buyback
11.17.2023
Santen Receives European Commission Approval for Catiolanze® (cationic emulsion of latanoprost 50μg/mL) for Lowering of Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension
11.07.2023
Santen Reports the 2nd Quarter Fiscal 2023 Consolidated Performance
11.01.2023
Santen Announces Status of Share Buyback
10.02.2023
Santen Announces Status of Share Buyback
IR News
Information
11.30.2023
Notice Regarding Closure of Official Facebook and X Accounts
02.07.2023
Santen selected as "The Sustainability Yearbook Member" by S&P Global in the United States
Information
News Archive
